» Articles » PMID: 30389296

A National Study of the Prevalence and Risk Factors Associated with Peripheral Arterial Disease from China: The China Hypertension Survey, 2012-2015

Overview
Journal Int J Cardiol
Publisher Elsevier
Date 2018 Nov 4
PMID 30389296
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Peripheral arterial disease (PAD) is the third leading cause of atherosclerotic vascular morbidity after coronary heart disease and stroke. Epidemiology data of PAD is very limited in low-income and middle-income countries. A national wide survey was conducted from October 2012 to December 2015 to assess the prevalence of PAD in China.

Methods: Data from the China Hypertension Survey (CHS). In total, 56,000 people aged 35 years or older were enrolled in this sub-survey for PAD, and 30,025 participants were eligible for analysis. Ankle-brachial index was measured using an automated ABI device (WatchBP Office device Microlife, China). PAD was defined by ABI and Edinburgh Claudication Questionnaire.

Results And Conclusions: Overall, 6.6% (estimated 45.3 million) of the Chinese adult population age 35 years or older had PAD. The weighted prevalence of PAD increased significantly after aged ≥75 years. There were no significant differences in PAD prevalence between urban and rural residents, as well as between males and females. Among individuals with PAD, only 4.9% (95% CI: 0%-10.1%) were aware of their condition, 1.9% (95% CI: 0%-4.0%) received revascularization, and 0.2% (95% CI: 0%-0.4%) achieved ABI >0.9. Older age, Han population, current smokers, education level, hypertension, CAD, diabetes, dyslipidemia, and rural residences all were significantly associated with an increased risk of PAD. In China, there is an increasing prevalence of PAD, but the awareness, treatment, and control were very low. Special attention should be paid to prevent and control PAD in China.

Clinical Trial Registration Number: ChiCTR-ECS-14004641.

Citing Articles

Aortic disease and peripheral artery disease.

Hu S J Geriatr Cardiol. 2024; 21(10):931-943.

PMID: 39619360 PMC: 11605506. DOI: 10.26599/1671-5411.2024.10.008.


Expression level and clinical significance of LncRNA PVT1 in the serum of patients with LEASO.

Su X, Yuan X, Li F, Yang G, Du L, Zhao F PeerJ. 2023; 11:e16057.

PMID: 37744231 PMC: 10516103. DOI: 10.7717/peerj.16057.


Report on cardiovascular health and diseases in China 2021: an updated summary.

In China T, Hu S J Geriatr Cardiol. 2023; 20(6):399-430.

PMID: 37416519 PMC: 10320777. DOI: 10.26599/1671-5411.2023.06.001.


Sex differences of the shared genetic landscapes between type 2 diabetes and peripheral artery disease in East Asians and Europeans.

Lu Z, Zhang H, Yang Y, Zhao H Hum Genet. 2023; 142(7):965-980.

PMID: 37341850 DOI: 10.1007/s00439-023-02573-x.


Combined Effect of Dynapenia and Abdominal Obesity on the Prevalence of Peripheral Artery Disease in Older Adults Over 75 Years Old in China.

Zheng Y, Sun Y, Zhang Z, Chen X, Han P, Xu C Clin Appl Thromb Hemost. 2023; 29:10760296231169503.

PMID: 37192648 PMC: 10192673. DOI: 10.1177/10760296231169503.